Chloroethylnorapomorphine: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Chloroethylnorapomorphine == | |||
<gallery> | |||
File:Chloroethylnorapomorphine.png | |||
</gallery> | |||
Latest revision as of 22:08, 16 February 2025
Chloroethylnorapomorphine is a chemical compound that belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties.
Chemical Structure[edit]
Chloroethylnorapomorphine has a molecular formula of C17H19ClN2O. It is a derivative of apomorphine, a type of dopamine agonist that is often used in the treatment of Parkinson's disease. The addition of a chloroethyl group to the apomorphine molecule results in chloroethylnorapomorphine.
Pharmacology[edit]
The pharmacological properties of chloroethylnorapomorphine are not well-studied. However, it is known that apomorphine and its derivatives work by stimulating dopamine receptors in the brain. This can help to alleviate symptoms of conditions like Parkinson's disease, which are caused by a lack of dopamine in certain parts of the brain. It is possible that chloroethylnorapomorphine has similar effects, but further research is needed to confirm this.
Synthesis[edit]
The synthesis of chloroethylnorapomorphine involves the reaction of apomorphine with chloroacetic acid in the presence of a base. This results in the formation of a chloroethyl group on the apomorphine molecule. The exact conditions required for this reaction, such as temperature and pressure, can vary depending on the specific method used.
Potential Uses[edit]
While the potential uses of chloroethylnorapomorphine are not yet fully understood, it is possible that it could have applications in the treatment of neurological disorders like Parkinson's disease. However, more research is needed to determine the safety and efficacy of this compound in a clinical setting.
See Also[edit]
References[edit]
<references />
